Abivax SA

ABVX · Healthcare

$113.67

Capitalización: 9.92B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Abivax SA? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

GlobeNewswire1 sept 2026, 11:00

NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier

Business Wire4 ago 2026, 7:00

Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer

GlobeNewswire30 jul 2026, 20:05

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod

Simply Wall St.26 jul 2026, 8:07

ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In?

MT Newswires24 jul 2026, 9:47

Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating